Cerebrolysin vs Dihexa

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Cerebrolysin is primarily a pain management peptide, while Dihexa is used for cognitive enhancement.

This page compares Cerebrolysin and Dihexa across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

CerebrolysinDihexa
CategoryPain ManagementCognitive Enhancement
Regulatory status (US)Research use onlyCompounding (Rx) — Apr 2026
Typical dosage5-10 mlResearch protocols vary
Frequencymultiple weeklyresearch
Reported benefitsNerve pain reduction, neuroprotection, stroke pain supportPowerful cognitive enhancement, potential neuroregeneration, memory improvement
Reported side effectsGenerally well-toleratedResearch compound. Long-term effects unknown

Key differences

Primary use. Cerebrolysin is categorised under Pain Management, while Dihexa falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. Dihexa: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple weekly). Dihexa is typically dosed at Research protocols vary (research).

Can you stack them?

Some protocols combine peptides, but stacking Cerebrolysin and Dihexa has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Cerebrolysin and Dihexa?
Cerebrolysin is primarily a pain management peptide, while Dihexa is used for cognitive enhancement. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026).
What is Cerebrolysin used for?
Neuropathic pain support.
What is Dihexa used for?
Potent cognitive enhancer.
Can you take Cerebrolysin and Dihexa together?
Some users combine peptides within a single protocol, but stacking Cerebrolysin and Dihexa has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Cerebrolysin or Dihexa FDA-approved?
Cerebrolysin is not FDA-approved; generally classified as a research compound. Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026).

Read the full articles

  • Cerebrolysin — full monograph: mechanism, research, dosing & references
  • Dihexa — full monograph: mechanism, research, dosing & references

More Pain Management comparisons

← All peptide comparisons